Literature DB >> 12881158

The inflammatory response to recycled pericardial suction blood and the influence of cell-saving.

Staffan Svenmarker1, Karl Gunnar Engström.   

Abstract

OBJECTIVE: To investigate the inflammatory and cellular response attributed to conventional cardiotomy suction vs cell-saver during cardiac surgery.
DESIGN: Thirty-three (n = 33) low-risk patients admitted for routine coronary artery bypass grafting were randomly assigned to two groups: cardiotomy suction or cell-saver for salvage of pericardial blood. The groups were compared with reference to proinflammatory cytokines, complement activation, leukocyte pattern, and haemolysis during and after cardiopulmonary bypass.
RESULTS: Pericardial suction blood contained significantly increased concentrations of free plasma haemoglobin, C3a, IL-6, IL-8, TNF-alpha, eosinophils and basophils compared with the systemic circulation. No differences were found for the terminal complement complex and lymphocytes, whereas overall concentrations of leukocytes, platelets and haemoglobin were decreased. Recycling of pericardial suction blood gave no systemic effects except from that of free plasma haemoglobin, which increased significantly. The cell-saver eliminated plasma haemoglobin, but no other effects could be demonstrated.
CONCLUSION: Cardiotomy suction is a major cause of haemolysis, but contributes insignificantly to the systemic inflammatory response. Treatment of shed mediastinal blood with a cell-saver reduces haemolysis and may lower the dose load of inflammatory components.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12881158     DOI: 10.1080/14017430310001465

Source DB:  PubMed          Journal:  Scand Cardiovasc J        ISSN: 1401-7431            Impact factor:   1.589


  8 in total

Review 1.  Autologous blood in obstetrics: where are we going now?

Authors:  Giancarlo Maria Liumbruno; Chiara Liumbruno; Daniela Rafanelli
Journal:  Blood Transfus       Date:  2011-10-25       Impact factor: 3.443

2.  Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.

Authors:  Stefania Vaglio; Domenico Prisco; Gianni Biancofiore; Daniela Rafanelli; Paola Antonioli; Michele Lisanti; Lorenzo Andreani; Leonardo Basso; Claudio Velati; Giuliano Grazzini; Giancarlo M Liumbruno
Journal:  Blood Transfus       Date:  2015-12-15       Impact factor: 3.443

3.  Recommendations for the transfusion management of patients in the peri-operative period. II. The intra-operative period.

Authors:  Giancarlo Maria Liumbruno; Francesco Bennardello; Angela Lattanzio; Pierluigi Piccoli; Gina Rossetti
Journal:  Blood Transfus       Date:  2011-04       Impact factor: 3.443

4.  The relationships between air exposure, negative pressure, and hemolysis.

Authors:  Joshua R Pohlmann; John M Toomasian; Claire E Hampton; Keith E Cook; Gail M Annich; Robert H Bartlett
Journal:  ASAIO J       Date:  2009 Sep-Oct       Impact factor: 2.872

5.  Intraoperative cell salvage during cardiac surgery is associated with reduced postoperative lung injury.

Authors:  Gerwin E Engels; Jan van Klarenbosch; Y John Gu; Willem van Oeveren; Adrianus J de Vries
Journal:  Interact Cardiovasc Thorac Surg       Date:  2015-12-23

Review 6.  Coronary artery surgery: cardiotomy suction or cell salvage?

Authors:  Kelvin Lau; Hetul Shah; Andrea Kelleher; Neil Moat
Journal:  J Cardiothorac Surg       Date:  2007-10-25       Impact factor: 1.637

7.  Circulating S100B and Adiponectin in Children Who Underwent Open Heart Surgery and Cardiopulmonary Bypass.

Authors:  Alessandro Varrica; Angela Satriano; Alessandro Frigiola; Alessandro Giamberti; Guido Tettamanti; Luigi Anastasia; Erika Conforti; Antonio D W Gavilanes; Luc J Zimmermann; Hans J S Vles; Giovanni Li Volti; Diego Gazzolo
Journal:  Biomed Res Int       Date:  2015-08-31       Impact factor: 3.411

Review 8.  Anemia and transfusions in patients undergoing surgery for cancer.

Authors:  Randal S Weber; Nicolas Jabbour; Robert C G Martin
Journal:  Ann Surg Oncol       Date:  2007-10-18       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.